Andrew ElBardissi
Independent DirectorDr. Andrew ElBardissi, M.D., is Partner & Board Director of Flower Orthopedics Corporation. He serves as Director at Alpfa Medical, Inc. He served as Director at Atlas Data Storage, Inc. He has B.S. in Biology from Harvard Business School. He has M.P.H in Quantitative Methods from Harvard University. He has M.B.A. from Harvard Business School. He has M.D. from Mayo Clinic College of Medicine. He has B.S. in Biology from Schreyer Honors College. He served as the Director of Reprieve Cardiovascular, Inc. He serves as Director of Medical Microinstruments, Inc. He served as Director at ADELA, Inc until December 2025. He serves as Director of Reprieve Cardiovascular, Inc. He served as Director of Pleno, Inc. until 2026. He serves as Director at Bitterroot Bio, Inc. He serves as a Director at Endologix, Inc. He was a Director at Singular Genomics Systems, Inc and also serves as its Director since. He serves as Director at Element Science. He serves as Director at Conventus, vWave, Sollis Therapeutics, Axon Therapies, InCarda Therapeutics, Inc., DNAMx, Inc., Epic Sciences. He served as Director at NeoChord, Inc. He serves as a Director of CathWorks Ltd. He served as Director of Sema4 Holdings Corp. (formerly known as Mount Sinai Genomics, Inc.). He has been an Independent Director of Acutus Medical, Inc. since July 2017. He serves on the Board of Directors at Encodia. He serves as Partner at Deerfield Management Company, L.P. Series C. He serves in the Board of MMI S.r.l. Prior to Deerfield, He was a Principal at Longitude Capital Management Co., LLC, where he focused on investments in medtech and biotechnology. Before that, he was an Associate in JPMorgan’s Healthcare Investment Banking practice.He received residency training in General Surgery at Harvard Medical School’s Brigham and Women’s Hospital and in Cardiothoracic Surgery at Stanford University. He serves as Director of Farapulse, Inc. He has been independently funded by the National Institutes of Health and the Agency for Healthcare Research and Quality, has authored over 30 publications in leading peer-reviewed scientific journals and has presented his research at numerous medical and surgical conferences. He has been a Director at DA32 Life Science Tech Acquisition Corp. He served on the Board of Aurion Biotech.
Positions
- Company NameAcutus Medical, Inc.Stock CodeAFIBPositionIndependent Director
